高级检索
当前位置: 首页 > 详情页

HLA-DR Expression Level in CD8(+) T Cells Correlates With the Severity of Children With Acute Infectious Mononucleosis

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

单位: [1]Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Lab Med, Wuhan, Peoples R China [2]Nanchang Univ, Affiliated Hosp 1, Dept Clin Lab, Nanchang, Jiangxi, Peoples R China
出处:
ISSN:

关键词: EBV infectious mononucleosis CD8(+) T cells CD4(+) T cells HLA-DR+ CD8(+) T cells

摘要:
BackgroundThis study aimed to assess the host immune signatures associated with EBV infection and its clinical value in indicating the severity of children with acute infectious mononucleosis (IM). MethodsTwenty-eight pediatric patients with IM aged 3-8 years were enrolled. The immune phenotypes and cytokine secretion capability of T cells were detected. ResultsThe percentages and absolute numbers of CD3(+) and CD8(+) T cells were significantly increased in IM patients compared with HCs. The percentages of Naive CD4(+) and CD8(+) T cells were decreased but with increased percentages of memory CD4(+) and CD8(+) T subsets. Our results showed the upregulation of active marker HLA-DR, TCR-alpha beta, and inhibitory receptors PD-1, TIGIT in CD8(+) T cells from IM patients, which suggested that effective cytotoxic T cells were highly against EBV infection. However, EBV exposure impaired the cytokine (IFN-gamma, IL-2, and TNF-alpha) secretion capability of CD4(+) and CD8(+) T cells after stimulation with PMA/ionomycin in vitro. Multivariate analysis revealed that the percentage of HLA-DR+ CD8(+) T cells was an independent prognostic marker for IM. The percentage of HLA-DR+ CD8(+) T cells was significantly correlated with high viral load and abnormal liver function results. ConclusionRobust expansion and upregulation of HLA-DR in CD8(+) T cells, accompanied with impaired cytokine secretion, were typical characteristics of children with acute IM. The percentage of HLA-DR+ CD8(+) T cells might be used as a prominent marker not only for the early diagnosis but also for indicating the severity of IM.

基金:

基金编号: 2017ZX10103005-007

语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2020]版:
大类 | 2 区 医学
小类 | 2 区 免疫学
最新[2025]版:
大类 | 2 区 医学
小类 | 2 区 免疫学
JCR分区:
出版当年[2019]版:
Q1 IMMUNOLOGY
最新[2023]版:
Q1 IMMUNOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2019版] 出版当年五年平均 出版前一年[2018版] 出版后一年[2020版]

第一作者:
第一作者单位: [1]Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Lab Med, Wuhan, Peoples R China
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:589 今日访问量:0 总访问量:441 更新日期:2025-06-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)